drug protocol number

Amendment 3 F02

drug sponsor

King Faisal Specialist Hospital & Research Centre Riyadh, Saudi Arabia

drug study

NINTEDANIB

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase